AFIB vs. NMRD, MOTS, UTRS, VIVE, DRTSW, ANZUW, ATAKW, BBLGW, BRSHW, and CTCXW
Should you be buying Acutus Medical stock or one of its competitors? The main competitors of Acutus Medical include Nemaura Medical (NMRD), Motus GI (MOTS), Minerva Surgical (UTRS), Viveve Medical (VIVE), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), and Carmell (CTCXW). These companies are all part of the "medical equipment" industry.
Acutus Medical vs. Its Competitors
Nemaura Medical (NASDAQ:NMRD) and Acutus Medical (NASDAQ:AFIB) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.
Nemaura Medical has higher earnings, but lower revenue than Acutus Medical.
Nemaura Medical has a beta of 0.5, indicating that its stock price is 50% less volatile than the S&P 500. Comparatively, Acutus Medical has a beta of -0.57, indicating that its stock price is 157% less volatile than the S&P 500.
Nemaura Medical has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Nemaura Medical's return on equity of 0.00% beat Acutus Medical's return on equity.
In the previous week, Acutus Medical had 1 more articles in the media than Nemaura Medical. MarketBeat recorded 1 mentions for Acutus Medical and 0 mentions for Nemaura Medical. Nemaura Medical's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.
4.4% of Nemaura Medical shares are owned by institutional investors. Comparatively, 56.9% of Acutus Medical shares are owned by institutional investors. 40.4% of Nemaura Medical shares are owned by insiders. Comparatively, 5.2% of Acutus Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Summary
Nemaura Medical beats Acutus Medical on 7 of the 10 factors compared between the two stocks.
Get Acutus Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for AFIB and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding AFIB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Acutus Medical Competitors List
Related Companies and Tools
This page (NASDAQ:AFIB) was last updated on 7/15/2025 by MarketBeat.com Staff
Free AFIB Stock Alerts